Chemokine receptor 9 high-expression involved in the migration and invasion of the non-small-cell lung cancer cells

Asian Biomedicine

Volumn 5, Issue 1, 2011, Pages 69-76

  Fan, Jian ^a   Zhang, Li ^a   Wang, Qi Long ^a   Lin, Hui ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

CCL25; CCR9; Invasion; Migration; Non small cell lung cancer

Indexed keywords

CHEMOKINE; CHEMOKINE CCL25; CHEMOKINE RECEPTOR CCR9; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHUS MUCOSA; CANCER CELL; CANCER PATIENT; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84871601161     PISSN: 19057415     EISSN: 1875855X     Source Type: Journal    
DOI: 10.5372/1905-7415.0501.008     Document Type: Article

References (29)

1. American Cancer Society. Cancer facts and figures. Atlanta (GA): American Cancer Society. 2007.
2. Maziak DE, Markman BR, MacKay JA, Evans WK. Photodynamic therapy in non-small cell lung cancer: A systematic review. Ann Thorac Surg. 2004;77:1484-91. (Pubitemid 38452417)
3. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000; 355: 479-85. (Pubitemid 30085163)
4. Campbell JJ, Butcher EC, Bowman EP. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing: developmental switches in chemokine response profiles during B cell differentiation and maturation. Curr Opin Immunol. 2000; 12:336-41.
5. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000; 12:121-7. (Pubitemid 30398626)
6. Koenecke C, Forster R.CCR9 and inflammatory bowel disease. Expert Opin Ther Targets. 2009; 13:297-306.
7. Richmond A. CCR9 homes metastatic melanoma cells to the small bowel. Clin Cancer Res. 2008; 14:621-3. (Pubitemid 351231138)
8. Amersi FF, Terando AM, Goto Y, Scolyer RA, Thompson JF, Tran AN, et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res. 2008; 14:638-45. (Pubitemid 351231142)
9. Valdivia-Silva, Franco-Barraza J, Silva AL, Pont GD, Soldevila G, Meza I, et al. García-Zepeda EA. Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis.Cancer Lett. 2009; 283:176-85.
10. Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW Jr. Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res. 2004; 10:8743-50. (Pubitemid 40053444)
11. van den Oord J. The CCR9-CCL25 axis mediates melanoma metastasis to the small intestine. Nature Clinl Pract Oncol. 2008; 5:440-1.
12. Johnson EL, Singh S, Johnson-Holidy C, Singh UP, Lillard JW. Role of CCL25-CCR9 interaction in ovarian cancer cell metastasis and survival. J Immunol. 2006; 176:S271.
13. Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. nvolvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res. 2009; 19:2962-70.
14. Xiaoling Tong, Lijun Zhang, Li Zhang, Hu M, Leng J, Yu B, et al. The mechanism of chemokine receptor 9 internalization triggered by interleukin 2 and interleukin4. Cell Molecul Immunol. 2009; 6:181-9.
15. Schneider BJ. Non-small cell lung cancer staging: Proposed revisions to the TNM system. Cancer Imaging 2008; 8:181-185
16. Huang CC, Aronstam RS, Chen DR, Huang YW. Zinc oxide nanoparticles induce oxidative stress and alter calcium homeostasis in human bronchial epithelial cells (BEAS-2B). Free Rad Biol Med. 2008; 45:S31.
17. Shafer SH, Williams CL. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment. Intern J Oncology. 2003; 23:389-400.
18. MacDonald TJ, DeClerck YA, Laug WE. Urokinase induces receptor mediated brain tumor cell migration and invasion. J Neuro-Oncology. 1998; 40:215-26. (Pubitemid 29054657)
19. Jinquan T, Frydenberg J, Mukaida N, Bonde J, Larsen CG, Matsushima K, et al. Recombinant human growth regulated oncogene-a induces T lymphocyte chemotaxis; a process regulated via interleukin-8 receptors by IFN-gamma, TNF-a, IL-4, IL-10 and IL-13. J Immunol. 1995; 155: 5359-68.
20. Wang CL, Wang CI, Liao PC, Chen CD, Liang Y, Chuang WY, et al. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res. 2009; 8:4428-40.
21. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature (Lond). 2001; 411:375-9.
22. Kakinuma T, Hwang SM. Chemokines, chemokine receptors, and cancer metastasis. J Leukocyte Biol. 2006; 79:639-51. (Pubitemid 44835596)
23. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M. Chemokines in tumor progression and metastasis. Cancer Sci. 2005; 96:317-22. (Pubitemid 41007465)
24. Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Müller W, Papadakis KA, et al. Role of beta 7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease. Gastroenterology. 2008; 134:2025-35. (Pubitemid 351790742)
25. Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE, et al. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J Surg Oncol. 2010; 8:62-9.
26. Sharma PK, Singh R, Novakovic KR, Eaton JW, Grizzle WE, Singh S. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide. Intern J Cancer. 2010; 9:2020-30.
27. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond). 2001; 410:50-6. (Pubitemid 32225831)
28. Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med. 2002; 195:1145-54. (Pubitemid 34517140)
29. Zaballos A, Gutierrez J, Varona R, Ardavín C, Marquez G. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol. 1999;162:5671-5. (Pubitemid 29314915)